Is Imago BioSciences Inc.’s (NASDAQ:IMGO) Stock Expensive Or Cheap At $18.48? – Marketing Sentinel
Home  »  Technologies   »  Is Imago BioSciences Inc.’s (NASDAQ:IMGO) Stock ...

Is Imago BioSciences Inc.’s (NASDAQ:IMGO) Stock Expensive Or Cheap At $18.48?

In last trading session, Imago BioSciences Inc. (NASDAQ:IMGO) saw 0.38 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $18.48 trading at -$1.47 or -7.37% at ring of the bell on the day assigns it a market valuation of $626.10M. That closing price of IMGO’s stock is at a discount of -93.07% from its 52-week high price of $35.68 and is indicating a premium of 20.94% from its 52-week low price of $14.61. Taking a look at company’s average trading volume of 179.05K if we extend that period to 3-months.

For Imago BioSciences Inc. (IMGO), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 1.20. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.39 in the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Imago BioSciences Inc. (NASDAQ:IMGO) trade information

Upright in the red during last session for losing -7.37%, in the last five days IMGO remained trading in the red while hitting it’s week-highest on Thursday, 01/13/22 when the stock touched $18.48 price level, adding 9.94% to its value on the day. Imago BioSciences Inc.’s shares saw a change of -22.06% in year-to-date performance and have moved -6.76% in past 5-day. Imago BioSciences Inc. (NASDAQ:IMGO) showed a performance of -7.83% in past 30-days.

Wall Street analysts have assigned a consensus price target of $35.33 to the stock, which implies a rise of 47.69% to its current value. Analysts have been projecting $34.00 as a low price target for the stock while placing it at a high target of $37.00. It follows that stock’s current price would drop -100.22% in reaching the projected high whereas dropping to the targeted low would mean a loss of -83.98% for stock’s current value.

IMGO Dividends

Imago BioSciences Inc. is more likely to be releasing its next quarterly report in February and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Imago BioSciences Inc. (NASDAQ:IMGO)’s Major holders

Insiders are in possession of 4.56% of company’s total shares while institution are holding 71.99 percent of that, with stock having share float percentage of 75.43%. Investors also watch the number of corporate investors in a company very closely, which is 71.99% institutions for Imago BioSciences Inc. that are currently holding shares of the company. Blackstone Inc is the top institutional holder at IMGO for having 3.38 million shares of worth $67.6 million. And as of Sep 29, 2021, it was holding 10.07% of the company’s outstanding shares.

The second largest institutional holder is Omega Fund Management, Llc, which was holding about 3.02 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 9.00% of outstanding shares, having a total worth of $60.47 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

On the other hand, Vanguard Total Stock Market Index Fund and Blackrock Funds-Health Sciences Opportunity Portfolio are the top two Mutual Funds which own company’s shares. As of Sep 29, 2021, the former fund manager was holding 0.56 million shares of worth $11.13 million or 1.66% of the total outstanding shares. The later fund manager was in possession of 0.45 million shares on Aug 30, 2021, making its stake of worth around $11.93 million in the company or a holder of 1.35% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam